Author:
Prasad G. Shyam,Govardhan P.,Deepika G.,Vakdevi V.,Sashidhar R. B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Reference38 articles.
1. Baker CS, Hall RJ, Evans TJ, Pomerance A, Maclouf J, Creminon C, Yacoub MH, Polak JM (1999) Cyclooxygenase-2 is widely expressed in Atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol 19:646–655
2. Belton O, Fitzgerald D (2003) Cyclooxygenase-2 inhibitors and atherosclerosis. J Am Coll Cardiol 41:1820–1822
3. Boamponsem AG, Boamponsem LK (2011) The role of inflammation in atherosclerosis. Adv Appl Sci Res 2:194–207
4. Broncel M, Cieslak D, Koter MM, Duchnowicz P, Mackiewicz K, Chojnowska JJ (2006) The anti-inflammatory and antioxidants effects of micronized fenofibrate in patients with visceral obesity and dyslipidemia. Pol Merkur Lekarski 20:547–550
5. Burleigh ME, Babaev VR, Oates BJ, Harris RC, Gautam S, Riendeau D, Marnett LJ, Marrow JD, Fazio S, Linton MF (2002) Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105:1816–1823
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献